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Autosomal recessive retinitis pigmentosa (arRP) is a clinically and
genetically heterogeneous retinal disease that causes blindness. Our
purpose was to identify the causal gene, describe the phenotype and
delineate the mutation spectrum in a consanguineous Quebec arRP family.
We performed Arrayed Primer Extension (APEX) technology to exclude
∼500 arRP mutations in ∼20 genes. Homozygosity mapping [single
nucleotide polymorphism (SNP) genotyping] identified 10 novel significant
homozygous regions. We performed next generation sequencing and whole
exome capture. Sanger sequencing provided cosegregation. We screened
another 150 retinitis pigmentosa (RP) and 200 patients with Senior-Løken
Syndrome (SLS). We identified a novel missense mutation in WDR19 ,
c.2129T>C which lead to a p.Leu710Ser. We found the same mutation in
a second Quebec arRP family. Interestingly, two of seven affected
members of the original family developed ‘sub-clinical’ renal cysts. We
hypothesized that more severe WDR19 mutations may lead to severe
ciliopathies and found seven WDR19 mutations in five SLS families. We
identified a new gene for both arRP and SLS. WDR19 is a ciliary protein
associated with the intraflagellar transport machinery. We are currently
investigating the full extent of the mutation spectrum. Our findings are
crucial in expanding the understanding of childhood blindness and
identifying new genes.
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Causal mutations of WDR19 in arRP and SLS
Retinitis pigmentosa (RP) is a well known inherited
retinal dystrophy that leads to progressive loss of vision,
and eventually complete blindness due to photoreceptor
cell death. RP is restricted to the eye, specifically the
retina and photoreceptors. Its prevalence is estimated to
be at 1/4000 (1–3). RP is caused by progressive loss
of rods followed by the loss of cones. Affected indi-
viduals start experiencing night blindness in the first
two decades of life. Peripheral visual field constriction
leads to ‘tunnel vision’, progressive loss of visual acu-
ity (VA) leads to complete loss of all vision (4). On
fundus exam, RP is classically characterized by retinal
atrophy, optic nerve head pallor, vascular narrowing
and a variety of peripheral retinal pigmentary deposits
including bone spicules. RP can be restricted to the
eye (non-syndromic) or a retinal degeneration indistin-
guishable from RP can be associated with a syndrome.
The syndromic features can be very obvious or very
subtle. Also, the syndromic features can be present at
the time of diagnosing the retinal degeneration, or they
may appear much later. Examples are Bardet–Biedl
syndrome (BBS), Usher Syndrome (USH) and Senior-
Loken Syndrome (SLS). The mode of inheritance of
RP may be autosomal dominant [autosomal dominant
retinitis pigmentosa (adRP); 5–25%], autosomal reces-
sive [autosomal recessive retinitis pigmentosa (arRP);
5–20%], rarely digenic, mitochondrial or X-linked [X-
linked retinitis pigmentosa (xlRP); 5–15%] (5). There
are currently 36 genes implicated in arRP that only
explain ∼50% of the cases (RetNet), illustrating that
many mutations and new genes still need to be dis-
covered. RPE65 , which is expressed in the retinal pig-
ment epithelium (RPE), PDE6A and PDE6B , which are
both phosphodiesterase subunits in the phototransduc-
tion cascade, EYS and USH2A, are among the most
well-known or common genetic etiologies (5, 6).
Interestingly, several genes associated with RP (in
patients without systemic disease) can also be mutated
in syndromic disorders such as BBS1 and USH2 (7,
8) and SLS which is an autosomal recessive disease
affecting primarily the kidney and retina, leading to
nephronophthisis (NPHP) and RP, respectively (9).
Of particular interest in RP and these syndromes is
the emergence of a group of genes and proteins that
function in and are localized to the cilium, the so-called
ciliary genes. In photoreceptor outer segments (OS,
which represent modified cilia), the stacked discs house
the proteins for visual function with several important
RP ciliary gene products, e.g. RPGR, RPGRIP1,
USH2A, CEP290, LCA5, and TULP1.
We identified an atypical form of arRP in a French-
Canadian family (Fig. 1) and excluded mutations in
all the known arRP genes. We hypothesized that this
family carries mutations in a novel RP specific gene
and subsequently identified homozygous mutations in
WDR19 . At the time of discovery (August 2011),
there was no published article in the literature linking
this gene to any human disease and specifically to
arRP. On re-evaluation of this family, we discovered
that several of the RP patients had sub-clinical renal
cysts, which prompted us to hypothesize that this gene
may be mutated in RP patients with frank kidney
failure, a disorder coined SLS. We then performed
mutation analysis in this gene in a cohort of patients
with RP in Quebec and a cohort with the syndromic
form of RP, namely SLS and identified more RP
families and several SLS families with mutations. At
this time, both Bredrup et al. in their original article
and Huber et al., in their review article, described the
involvement of WDR19 , a ciliary gene, in a variety of
ciliopathies including Sensenbrenner, Jeune syndrome
and isolated NPHP (10, 11). Similarly, Halbritter et al.
reported the first case of Caroli disease, which is a
rare inherited disorder most commonly characterized by
congenital cystic dilatation of the intrahepatic biliary
ducts secondary to ectasia, caused by mutations in
WDR19. However, there is yet no study confirming
clearly the involvement of WDR19 in arRP as well as
in SLS (12).
In the process of identifying a novel gene for RP and
SLS, we also identified a novel genotype–phenotype
correlation in the arRP families. We illustrate that
the combined use of Arrayed Primer Extension
(APEX) technology, homozygosity mapping by single
nucleotide polymorphism (SNP) genotyping and next
generation sequencing (NGS), can rapidly and reliably
lead to new gene discovery.
Materials and methods
This study was approved by the Institutional Review
Board (IRB) committee at the McGill University Health
Centre (MUHC), according to the tenets of Helsinki.
Informed consents were obtained from all patients.
Ophthalmic examinations included best-corrected VA,
slit-lamp biomicroscopy, and funduscopy. Goldmann
kinetic perimetry [Goldmann visual fields (GVF)] was
performed with four targets (IV/4e, III/4e, I/4e and
I/3e) testing from non-seeing retina to seeing retina.
In vivo retinal imaging was performed in a subset
of patients by optical coherence tomography (OCT)
(Heidelberg Engineering) and lipofuscin metabolism
was mapped using the fundus autofluorescence (FAF)
module (Heidelberg Engineering).
To identify the causal gene of the proband in
family A, we used a novel four-step sequential process.
First, we excluded all known arRP mutations (700
mutations in 28 arRP genes, version 2012) using APEX
technology (Asper Ophthalmics). We then performed
SNP Homozygosity Mapping (Illumina Infinium HD
660K technology, San Diego, CA) followed by whole
exome capture (WEC, Agilent SureSelect V3, Santa
Clara, CA) and NGS (Illumina Hiseq, San Diego, CA)
with a particular focus on the identified homozygous
regions. We finally confirmed the causal mutations
using Sanger sequencing.
We then used a pipeline approach to exclude variants
and we excluded the found mutation from 500 normal
controls. Cosegregation of the mutations was then
performed in family A and B by Sanger sequencing. We
then screened ∼150 RP patients (mostly from Quebec),
96 SLS patients, and 96 patients with more severe
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(a)
(b)
(c)
(d)
Fig. 1. (a) Family A pedigree. (b) Retinal photo showing an atrophic maculopathy and severe narrowing of the blood vessels and temporal pallor of
the optic nerve head. (c) Fundus autofluorescence showing the ‘bear claw’ maculopathy and hypo-fluorescence in the fovea. (d) Optical coherence
tomography of the macula showing extensive loss of the inner segment/outer segment junctions and photoreceptors, with inner retinal changes,
retinal thinning and foveal debris. (e) Renal ultrasound showing the renal cyst of the probands of family A.
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ciliopathy by applying a CEL1 endonuclease based
heteroduplex DNA cleavage procedure (13) followed by
Sanger sequencing in an attempt to find other families
and to delineate the full mutation spectrum of the gene.
SNP genotyping
Whole-genome SNP genotyping (Affymetrix, Santa
Clara, CA) was performed to identify homozygous
regions in family A (6). The DNA samples for SNP
analysis were purified (QIAamp DNA Mini Kit; Qia-
gen, Valencia, CA) and then genotyped. The SNP
genotypes were analyzed for homozygous regions
(ExcludeAR sheet; Excel, Microsoft, Redmond, WA).
Chromosomal segments were accepted as having sig-
nificant homozygous regions if they contained ≥300
consecutive homozygous SNPs, as the likelihood that
this would occur by chance is less than 1:100 (14).
Whole exome capture and next generation sequencing
The pre-capture library was prepared following the
manufacturer’s protocol (Illumina); 2 μg of link-ligated
DNA from the proband of family A was used for
the capture reaction. Agilent SureSelect V3 exome
capture was performed according to the company’s
standard protocol. The amplified capture product was
sequenced on Hiseq 2000 (Illumina). We removed
adaptor sequences and quality trimmed reads using the
Fastx toolkit (http://hannonlab.cshl.edu/fastx_toolkit/)
and then used a custom script to ensure that only read
pairs with both mates present were subsequently used.
Reads were aligned to hg19 with BWA 0.5.9, and indel
realignment was carried out using the Genome Analysis
Toolkit (GATK) (15). Duplicate reads were then
marked using Picard (http://picard.sourceforge.net/) and
excluded from downstream analyses. We assessed
coverage of consensus coding sequence (CCDS) bases
using the GATK, which showed that >93% of CCDS
bases were covered by at least 10 reads. Single
nucleotide variants (SNVs) and short insertions and
deletions were called using samtools pileup, and were
then quality filtered to require at least 20% of reads
supporting the variant call. Variants were annotated
using both Annovar (16) and custom scripts to identify
whether they affected protein coding sequence, and
whether they had previously been seen in dbSNP132,
the 1000 genomes dataset (November 2011), the
NHLBI GO exomes, or in approximately 500 exomes
previously sequenced at our center.
Sanger sequencing and cosegregation
Direct polymerase chain reaction (PCR) and Sanger
sequencing were used to validate the mutations in
the proband, their parents and siblings. Primers were
designed using primer design tool ‘Primer3’ (17). Each
amplicon was 300–500 bp in length and was sequenced
directly with an ABI 3730 (Life Technologies Corpo-
ration, Carlsbad, CA) machine in both forward and
Table 1. Result of homozygosity mapping in family A: proband
(IV:4)
CHR Size (millions BP) NSNP Rank
3 20.6 4307 1
18 19.8 5165 2
8 19.6 4265 3
1 14.6 3716 4
19 14.2 3631 5
20 12.5 4415 6
15 12.3 3281 7
22 11.7 3270 8
9 10.3 3225 9
4 7.3 1589 10
4 7.2 2126 11
CHR, chromosome; NSNP, number of single-nucleotide
polymorphism.
reverse directions. Each read was aligned to the ref-
erence sequence and the base changes were identified
with the sequencher software program.
Results
Genotype
Autosomal recessive retinitis pigmentosa (arRP)
In the consanguineous family A (Fig. 1), after excluding
known arRP mutations using APEX technology, we
proceeded with whole genome SNP genotyping and
homozygosity mapping, (Table 1), and we ranked the
sizes of the homozygous regions in descending order.
We found a total of 150 Mb of homozygosity most
likely by descent in this Quebec family with a total of
11 significant regions. The largest homozygous region
was found on chromosome 3 (20.6 Mb) while the
smallest one was found on chromosome 4 (7.2 Mb).
Assuming consanguinity and recessive mutations in the
causal gene, it became evident from the non-overlap
between known retinal dystrophy loci and our identified
homozygous regions that we were very likely dealing
with a new gene for arRP.
Without any potential lead candidate gene, we
then used WEC/NGS with a particular focus on
the homozygous regions identified earlier in family
A. A TMEM5 splice site mutation was found on
chromosome 1, but this change did not cosegregate
in the family. We then concentrated on a candidate
missense mutation in AIFM3 on chromosome 22.
Unfortunately, this variant did not cosegregate either.
Finally, we identified a missense variant in WDR19
on chromosome 4, the smallest homozygous region.
Using Sanger sequencing we confirmed the mutation
and found cosegregation in family A (Fig. 2). The
identified variant is a homozygous missense mutation
c. 2129T>C, p. Leu710Ser in WDR19 (Fig. 2).
The Leu710Ser mutation is predicted to be harmful
according to polyphen2, damaging according to sift
and evolutionarily highly conserved, as the Leucine is
always present even in Caenorhabditis elegans (Fig. 2).
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(a)
(b)c (c)
(d)
Fig. 2. (a) Gene and protein structure of WDR19 and IFT144, showing the protein domains and the positions of all the mutations found in this
study and in Bredrup et al. showing that most mutations are in protein domains except the p. L710S mutation. (b) Conservation of the Leucine
at position 710 in IFT144 (WDR19) among species. (c) Sanger sequencing results of the WDR19 mutations in Family A. (d) Sanger sequencing
results of the WDR19 mutations in Senior-Loken syndrome patients.
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(a)
(b) (c) (d)
(e)
Fig. 3. (a) Family B pedigree. (b) Retinal photo showing an atrophic maculopathy and severe narrowing of the blood vessels and temporal pallor
of the optic nerve head. (c) Peripheral bone spicules, extensive. (d) Fundus autofluorescence showing the ‘bear claw’ maculopathy and the hypo-
fluorescence in the fovea. (e) Optical coherence tomography of the macula showing extensive loss of the inner segment/outer segment junctions
and photoreceptors, with inner retinal changes, retinal thinning and foveal debris.
WDR19 is a ciliary gene that encodes the intraflagellar
transport 144 (IFT144) protein, and recently associated
with a human disease during our study (10). In order
to investigate the full mutation spectrum of WDR19 in
arRP and its frequency, we assembled an arRP cohort
from Quebec. After Sanger sequencing of an unsettled
cohort of 150 arRP from the Quebec province, we
identified the same homozygous mutation again in a
second Quebec arRP family B (Fig. 3). The mutation
was not seen in 200 French-Canadian healthy control
individuals.
We reassessed the phenotype of both families and
discovered that two of seven family A affected
members had ‘sub-clinical’ renal cysts (Fig. 1). This
unusual finding surprised us, as arRP is not known
to be associated with subclinical renal cysts. We
performed renal ultrasounds and renal function by urine
biochemistry. Fig. 1 shows the large cysts in both
kidneys. Urine and blood biochemistry were normal,
strongly suggesting normal renal function. This led us
to hypothesize that more severe mutations in WDR19
may be involved in more severe and more complex
phenotypes, involving other tissues such as kidney,
brain and others. First we hypothesized that our kidney
cysts were a ‘forme fruste’ of NPHP and turned our
attention to SLS, which represents a ciliopathy with
retinal and kidney involvement.
Senior-Løken syndrome
Using the same genetic approach, we screened 96
patients with SLS and found five families (7%)
in which WDR19 was mutated (Table 2). Again,
all the mutations were predicted to be harmful.
We found compound heterozygous and heterozygous
mutations (Table 2), and we identified both missense
and frameshift mutations in WDR19 (Fig. 2). They
were confirmed by Sanger sequencing and found to
cosegregate in their respective families (Fig. 2). All
mutations currently known are shown in Fig. 2.
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Phenotype of the arRP families carrying the WDR19
missense mutation (p.Leu710Ser)
Family A
The proband (IV:4) in family A is a 50-year-old
man from a consanguineous French-Canadian family
(Fig. 1). His acuities are hand motions only (HM) and
his GVF are abnormal with severe constriction down to
5O. Electroretinograms (ERGs) were undetectable. His
fundus examination showed 360O fine bone spicules in
the periphery and severely attenuated vessels occulus
uterque (OU) (Fig. 1). Both optic discs showed slight
temporal pallor. There is a striking and significant
macular atrophy (Fig. 1). On FAF this maculopathy has
a ‘bear claw’ appearance (Fig. 1). The in vivo retinal
architecture by OCT reveals considerable thinning of
the fovea, a poorly delineated photoreceptor layer
with extensive loss of the inner segments (IS)/OS
junctions as well as foveal debris, which are likely
attributed to the maculopathy described earlier (Fig.
1). When we reviewed the phenotype of family A, we
discovered that two of seven members reported having
‘kidney problems’. A pelvic ultrasound scan (US) was
performed and confirmed the presence of a sub-clinical
large exophytic cysts (Fig. 1). The urine analysis and
blood biochemistry were within normal ranges. The
patient also presented with mild cognitive impairment.
Family B
The proband of family B (II:1) is a 43-year-old female
also from a French-Canadian family not known to
be related to family A (Fig. 3). We found the same
homozygous p. Leu710Ser mutation in WDR19 , sug-
gestive of a founder mutation in Quebec. Her VA was
20/100. The GVF show bilateral large central scotomas.
On fundus examination (Fig. 3), bone spicules, vessels
attenuation and optic disc pallor can be appreciated
with a very similar atrophic foveal lesion in both eyes
as was seen in family A. Furthermore, the atypical
‘bear claw’ shaped maculopathy can be again clearly
visualized on FAF (Fig. 3). The OCT shows marked
photoreceptor loss and IS/OS junction loss with atrophy
with mild foveal edema (Fig. 3). There were no renal
cysts or any other renal abnormalities in this proband.
Phenotype of the SLS families carrying the WDR19
mutations
All of the reported five patients exhibited retinal dys-
trophy and NPHP. Additionally, most showed specific
phenotypic characteristics involving different organ sys-
tems. These included growth retardation and cognitive
impairment, hip dysplasia and scoliosis, ventricular sep-
tum defect as well as gestational polyhydramnios and
Jeune asphyxiating thoracic dystrophy (Table 2).
Discussion
Cilia and flagella are subcellular ‘antenna-like’
organelles that project from the cell surface. They are
highly conserved in evolution as they play important
roles in cell motility, sensory stimuli reception, and
early developmental processes. In humans, cilia are
almost ubiquitously present on many different cell
types. Photoreceptor OS in the retina represent modi-
fied cilia. Defects in their structure or function lead to
a wide range of developmental problems and diseases,
including RP and SLS (18–21). The assembly and
further structural and functional maintenance of cilia
and flagella are dependent on the process of IFT,
which brings the proteins to the place of work (in
the photoreceptor this is the OS). The phylogeneti-
cally highly conserved IFT represents a bidirectional
machinery required for cilia development, maintenance
and signaling. The anterograde (from the base to the
tip) and retrograde movement (from the tip back to
the base) requires three components; motor proteins,
IFT particles and the cargo (proteins destined for the
OS). For the anterograde movement, kinesin motors
and the IFT-B particles are used, while for retrograde
movement, dynein motors and IFT-A particles are
utilized. Retrograde movement not only recycles
the proteins but also participates in sonic hedgehog
signaling (22). How the IFT A and B particles are
assembled at the ciliary base, how the correct cargo is
chosen and bound to the IFT particles and moved to
the ciliary tip, exchanged and then released at the base
on the other side of the cilium is an area of intense
research and current interest.
WDR19 , also known as DYF-2 (in C. elegans)
is expressed in the retina, particularly in photore-
ceptors but also many other tissues and encodes the
IFT144 protein particle. IFT144 is an IFT-A compo-
nent, involved in retrograde movement of cargo in the
cilium. IFT-A components (genes) have been found to
be predominantly mutated in skeletal diseases. WDR19
encodes a large protein with 1342 amino acids, 37
exons and three different types of domains in the
IFT144 protein. There are six WD40 domains, which
are short structural motifs of 40 amino acids end-
ing in the tryptophan–aspartic-acid dipeptide (W–D),
two transmembrane domains (TM), and six tetratri-
copeptide (TPR) domains. The common function of
all WD40 containing proteins is the coordination of
the assembly of multi-protein complexes. TPR domains
mediate protein–protein interactions and multiprotein
complexes.
When we started this genetic study, WDR19 muta-
tions were not known to be associated with human
disease. During our study, a link between WDR19
and human disease was found by Bredrup et al. (10).
Because of its crucial ciliary function and conservation
between man and C . elegans (22, 23), we argued that it
was a prime candidate gene for arRP. We then identified
a novel homozygous missense mutation (p. Leu710Ser)
in WDR19 in two unrelated French-Canadian RP fam-
ilies. This illustrates that WDR19 is crucial to pho-
toreceptor survival or maintenance, and suggests that
p.Leu710Ser represents a founder mutation in the Que-
bec population. Our further studies suggest that WDR19
mutations are a rare cause of arRP. Striking is the
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unusual ‘bear track’ maculopathy in both families (Figs
1 and 3), suggesting a novel genotype–phenotype cor-
relation. Finding sub-clinical renal cysts in some of
the RP patients in one of the families (Fig. 1) are
highly unusual, suggesting to us to investigate more
severe ciliopathies. Our hypothesis that more severe
WDR19 mutations lead to more severe systemic dis-
ease including SLS was confirmed when we identified
frameshift mutations in WDR19 in patients with SLS.
To our knowledge, this is the first study reporting
the direct involvement of WDR19 in arRP as well as in
SLS. In fact, both diseases are known in part to be based
on ciliary pathologies. In arRP, the photoreceptors,
which are the structures reported to be damaged, are
derived from a ciliary ancestor. SLS is a syndrome
of NPHP associated with RP. NPHP is characterized
by anemia, polyuria, polydipsia, isosthenuria and cysts
mainly at the corticomedullary border of the kidney.
The latter is a form of ciliopathy that develops due to
an excess vacuole loss of normal tissue (24).
Once we confirmed that WDR19 mutations are a
rare cause of RP and SLS, we hypothesized fur-
ther that more severe human phenotypic manifesta-
tions could also result from this ubiquitously expressed
gene. During our study, Bredrup et al. answered our
suspicion in their study identifying WDR19 muta-
tions in Sensenbrenner, Jeune syndrome and isolated
NPHP (10). Remarkably, their group also identified the
p.Leu710Ser mutation in several different disease enti-
ties/ciliopathies. They reported compound heterozygous
mutations in Sensenbrenner syndrome (p.Leu710Ser
and p.Arg1103X), combining the Leu710Ser missense
mutation of our study with a nonsense mutation that
likely leads to pre-mature WDR19 protein trunca-
tion. Sensenbrenner is also known as cranioectoder-
mal dysplasia-1, an autosomal recessive disorder with
sagittal craniosynostosis (early closure of the scalp and
orbital sutures), and facial, ectodermal and skeletal
anomalies. The most prominent phenotypic features of
Sensenbrenner are remarkably bony defects, with dys-
morphic facies, short limbs, abnormal teeth, skin laxity
and hernias. Sensenbrenner patients can have normal
retinas and normal kidneys or they can develop RP or
nephronophtisis.
They also found the same homozygous missense
mutation in Jeune syndrome (p.Leu710Ser), a rare
autosomal recessive potentially lethal congenital
dwarfism, also known as familial asphyxiating thoracic
dystrophy. The phenotype is again dominated by the
skeletal abnormalities, and death is often due to narrow
thorax and respiratory failure. Kidney disease may
be seen. Finally they found compound heterozygous
mutations in isolated NPHP (p. Val345Gly and p.
Tyr1023X), again combining a missense and nonsense
mutation (10).
Among the seven patients reported in this study, three
had novel mutations in WDR19 (Table 2). In particular,
p.Val68Asp resulted in isolated case of retinal dystrophy
and NPHP while p.Ala30Pro and p.Gly109Glu lead
to severer phenotypes involving skeletal and cardiac
anomalies as well as gestational complications and
cognitive impairment, respectively. The remaining four
patients had their mutations previously reported by
various groups (10–12). Besides their different severity
and syndromic manifestations, all the mutations share
a common pathophysiology related to a dysfunctional
ciliopathy in a specific organ system. What dictates the
involvement of a specific organ system vs another could
be related to the mutation itself as well as the presence
of modifying genes/mutations. Functional studies need
to be undertaken to fully understand this phenomenon.
It is of great scientific interest that the p. Leu710Ser
mutations in our two arRP families are the same as
those identified by Bredrup et al. in families with
Sensenbrenner and Jeune syndromes (10). Aside from
the important clinical fact that this mutation can easily
be tested as the first genetic test in RP patients with
cysts and in new children diagnosed with the much
more severe and deadly Jeune and Sensenbrenner syn-
dromes, is the suggestion of modifier effects. These
data of a phenotype severity spectrum (RP, RP with
cysts, isolated nephronophtisis, SLS, Sensenbrenner,
and lethal Jeune syndrome) associated with the same
missense mutation (p. Leu710Ser) strongly suggest the
presence of modifying genes/mutations, additional cil-
iary mutations, genetic load or micro-environment vari-
ations (25–28). For instance, a change in the penetrance
of retinal degeneration among ciliopathies were associ-
ated with mutations in RPGRIP1L. Similarly, mutations
in AHI1 were reported to cause retinal phenotypic vari-
ations in NPHP16 (25, 29, 30). In fact, Hildebrandt et al.
suggested the possible presence of a modifier gene in
patients with NPHP-associated ciliopathies (22). Addi-
tionally, in their studies in Dync2h1 knockout mice,
Ocbina et al. showed the presence of a ‘rescue route’
based on mutations in Ift172 and Ift122 (31). Such
mutations could serve as modifier effects in gene encod-
ing for IFT-associated proteins and thus contribute to
the phenotypic severity spectrum. The p. Leu710Ser
mutation is not found in a WDR19 protein domain but
the Leucine is conserved all the way down the evo-
lutionary ladder to the nematode C . elegans (Fig. 2).
However, its effects are severe, as Bredrup et al. found
that in fibroblast cultures of Sensenbrenner patients,
there was no IFT144 protein in the cilia, thus indicat-
ing a complete loss of function of IFT144 due to the p.
Leu710Ser mutation (10). This missense mutation may
therefore be acting as a null allele.
Conclusion
In conclusion, we show that WDR19 mutations are
a rare cause of arRP and SLS. Our results suggest
that there is a large phenotypic disease and severity
spectrum associated with WDR19 mutations. These
manifestations range from isolated cases of arRP, arRP
with cysts, isolated NPHP to syndromal manifestations
seen in SLS and even very severe manifestations such
as those in Sensenbrenner syndrome and the lethal
Jeune syndrome. In the process of re-evaluating and
delineating the WDR19 mutation phenotype in arRP,
we discovered a novel genotype–phenotype correlation,
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a very distinct ‘bear claw maculopathy’ (Figs 1 and 3).
It will be interesting to investigate the maculopathies
referred to in SLS patients and in those noted in the
Bredrup et al. study. It is important to re-evaluate
patients after the genotype has been determined, and
to search for subtle subclinical phenotypes. Syndromic
disease genes may also cause isolated diseases without
the systemic manifestations.
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